PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Pentaerithrityl Tetranitrate→

Pentaerithrityl Tetranitrate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
78-11-5
Molecular formula
C5H8N4O12
Molecular weight
316.14 g/mol
Drug class
Long-acting organic nitratenitric-oxide-donor antianginal vasodilator
Mechanism of action
Bioactivation of the organic nitrate releases nitric oxide or related nitrosating species, activating soluble guanylate cyclase and increasing cyclic GMP in vascular smooth muscle. Predominant venodilation reduces venous return and myocardial preload, lowering myocardial oxygen demand.
Indications / reported uses
  • Prevention and long-term management of angina pectoris with authorised oral formulations; it is not intended for immediate relief of an acute angina attack.

Sources: https://pubchem.ncbi.nlm.nih.gov/compound/6518 · https://pubchem.ncbi.nlm.nih.gov/compound/Pentaerythritol-tetranitrate · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Pentaerithrityl Tetranitrate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Pentaerithrityl Tetranitrate Permitted Daily Exposure (PDE) report (the Pentaerithrityl Tetranitrate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Pentaerithrityl Tetranitrate Occupational Exposure Limit (OEL) report (the Pentaerithrityl Tetranitrate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.